Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Diamondcutter who wrote (4174)	5/15/1998 1:57:00 PM
From: epicure	Read Replies (1) \| Respond to of 7041

>Zonagen also announced that its 1993 research agreement with German pharmaceutical manufacturer Schering AG relating to zona pellucida-based contraceptive vaccines is expected to lapse on or before June 9, 1998. Under the terms of the agreement, Zonagen was required to fund all development until a lead compound was developed which met certain specified standards for use in clinical trials. All rights under the agreement revert back to Zonagen with no further obligation to Schering AG. Schering AG is not affiliated with Schering-Plough Corporation.< I was a little interested in this. I assume it means no "lead" compound was developed- in other words, a failure.

To: Diamondcutter who wrote (4174)	5/15/1998 5:03:00 PM
From: oexwa	Read Replies (1) \| Respond to of 7041

RE: 10-Q - No real surprises here. Nobody expected them to make money since no SGP payments were scheduled or due. I was looking to see how they would handle the numerous class action suits that have been filed. I guess that they have taken the Ostrich approach and chosen to put their head in the sand. (If one ignores them, they will go away.) Normally, companies make some comment such as, "Management believes the lawsuits are without merit and will not have a material effect on operations", or some such. As far as I know, they have never commented on any of the dozen or so suits. If they have, would someone please direct me to their response? Maybe it is in the full filing. Will check next week,